tiprankstipranks
Trending News
More News >
Sanofi (FR:SAN)
:SAN
France Market
Advertisement

Sanofi (SAN) Drug Pipeline

Compare
250 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Duvakitug
Crohn's Disease
Phase III
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sep 15, 2025
Duvakitug
Ulcerative Colitis
Phase III
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sep 15, 2025
Duvakitug
Ulcerative Colitis
Phase III
Recruiting
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Sep 15, 2025
Duvakitug
Crohn's Disease
Phase III
Recruiting
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Sep 15, 2025
Sar445229
Healthy Volunteers
Phase I
Not Yet Recruiting
A Bioequivalence Study of Amlitelimab Delivered by 2 Different Devices in Healthy Adult Participants
Aug 21, 2025
Menacyw Conjugate Vaccine, Menac Conjugate Vaccine
Meningococcal Infection, Healthy Volunteers
Phase III
Not Yet Recruiting
Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in China
Aug 14, 2025
Belumosudil
Chronic Graft Versus Host Disease
Phase IV
Not Yet Recruiting
A Study to Investigate Safety of Belumosudil in Participants Aged 12 Years and Above, With Chronic Graft-versus-host Disease (cGVHD)
Aug 14, 2025
Nirsevimab
Rsv Immunization
Phase IV
Recruiting
Study of Monoclonal Antibody Nirsevimab Against Respiratory Syncytial Virus (RSV) in Participants up to 24 Months of Age in India
Jul 31, 2025
Belumosudil
Chronic Graft Versus Host Disease
Phase II
Not Yet Recruiting
A Study of Belumosudil in Children With Chronic Graft Versus Host Disease (schoolROCK)
Jul 25, 2025
Teplizumab
Type 1 Diabetes Mellitus
Phase III
Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
Jul 20, 2025

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does Sanofi (SAN) have in its pipeline
      SAN is currently developing the following drugs: Duvakitug, Duvakitug, Duvakitug. These drug candidates are in various stages of clinical development as the company works toward FDA approval.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis